<p>直觉外科（NASDAQ:ISRG - 获取免费报告）在周五发布的报告中，Wells Fargo &amp; Company 将其目标价格从 600.00 美元上调至 654.00 美元，MarketScreener 报道。该券商目前对这家医疗设备提供商的股票给予 “增持” 评级。Wells Fargo &amp; Company 的目标价格表明，相较于公司之前的收盘价，存在 19.48% 的潜在上涨空间。</p>
<p>获取 <strong>Intuitive Surgical</strong> 警报：</p>
<ul>
<li>1.34 亿美元的内部交易：这对 KMI、ISRG 和 QS 可能意味着什么</li>
</ul>
<p>其他一些券商最近也发布了关于 ISRG 的报告。Leerink Partners 将直觉外科的目标价格从 593.00 美元上调至 600.00 美元，并在 10 月 22 日的研究报告中给予该公司 “跑赢大盘” 评级。Sanford C. Bernstein 在 10 月 21 日的研究报告中重申了 “跑赢大盘” 评级，并设定了 685.00 美元的目标价格。BTIG Research 在 10 月 22 日的报告中将直觉外科的目标价格从 529.00 美元上调至 589.00 美元，并给予该股票 “买入” 评级。Weiss Ratings 在 10 月 31 日的研究报告中重申了对直觉外科股票的 “持有（c）” 评级。最后，HSBC Global Research 在 10 月 23 日的研究报告中将直觉外科的股票评级上调至 “强力买入”。两位股票研究分析师给予该股票 “强力买入” 评级，十六位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，共识目标价格为 608.79 美元。</p>
<p><strong>查看我们关于直觉外科的最新研究报告</strong></p>
<h2>直觉外科股票表现</h2>
<ul>
<li>在特朗普关税政策下表现突出的三只股票</li>
</ul>
<p>NASDAQ:ISRG 周五开盘价为 547.36 美元。直觉外科的 52 周低点为 425.00 美元，52 周高点为 616.00 美元。该公司的 50 日移动平均价格为 527.82 美元，200 日移动平均价格为 505.98 美元。该公司的市值为 1962.2 亿美元，市盈率为 72.40，市盈增长比率为 5.11，贝塔值为 1.68。</p>
<p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近于 10 月 21 日发布了其财报。这家医疗设备提供商报告本季度每股收益（EPS）为 2.40 美元，超出市场共识预期的 1.99 美元，超出幅度为 0.41 美元。该公司本季度的收入为 25.1 亿美元，而分析师预期为 24.1 亿美元。直觉外科的股本回报率为 15.08%，净利润率为 28.58%。直觉外科的季度收入同比增长 22.9%。在去年同期，该公司每股收益为 1.84 美元。整体来看，卖方分析师预测直觉外科在当前年度的每股收益将达到 6.43 美元。</p>
<h2>内部活动</h2>
<ul>
<li>为什么直觉外科对长期投资者来说是个明智的选择</li>
</ul>
<p>在相关消息中，内部人士 Gary S. Guthart 于 10 月 24 日星期五出售了 28,800 股公司的股票。该股票以平均价格 547.56 美元出售，总价值为 15,769,728.00 美元。交易完成后，该内部人士直接持有 27,027 股公司股票，价值约为 14,798,904.12 美元。这笔交易代表其持股比例减少了 51.59%。该交易已在证券交易委员会的备案中披露，相关信息可通过此链接访问。此外，首席执行官 David J. Rosa 于 10 月 24 日星期五出售了 24,500 股公司的股票。该股票以平均价格 547.55 美元出售，总交易额为 13,414,975.00 美元。出售后，首席执行官直接持有 234,256 股公司股票，价值为 128,266,872.80 美元。这笔交易使其持股比例减少了 9.47%。该出售的 SEC 备案提供了更多信息。在过去三个月中，内部人士已出售 109,043 股公司股票，价值为 60,816,225 美元。当前 0.70% 的股票由公司内部人士持有。</p>
<h2>对直觉外科的对冲基金看法</h2>
<p>几家对冲基金最近对 ISRG 的持仓进行了调整。Alecta Tjanstepension Omsesidigt 在第三季度将其在直觉外科的股份增加了 25.4%。Alecta Tjanstepension Omsesidigt 目前持有 212,800 股该医疗设备提供商的股票，价值为 95,160,000 美元，此前在该期间内又购买了 43,100 股。Saranac Partners Ltd 在第三季度购买了直觉外科的新股份，价值约为 4,325,000 美元。瑞士人寿资产管理有限公司在第三季度将其在直觉外科的股份增加了 7.7%。瑞士人寿资产管理有限公司目前持有 67,483 股该医疗设备提供商的股票，价值为 30,180,000 美元，此前在该期间内又收购了 4,824 股。Cambria Investment Management L.P.在第三季度购买了直觉外科的新股份，价值约为 318,000 美元。最后，KERR FINANCIAL PLANNING Corp 在第三季度购买了直觉外科的新股份，价值约为 33,000 美元。当前 83.64% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>关于直觉外科</h2>
<p>（获取免费报告）</p>
<p>直觉外科公司开发、制造和销售产品，使医生和医疗服务提供者能够提高美国及国际上微创护理的质量和可及性。该公司提供达芬奇手术系统，能够以微创方式进行复杂手术；以及 Ion 内腔系统，扩展其商业产品范围，涵盖微创肺活检的诊断程序。</p>
<h2>另见</h2>
<ul>
<li>五只我们认为比直觉外科更好的股票</li>
<li>股票行业对成功投资的重要性是什么？</li>
<li>4 只填补重油缺口的加拿大石油股票</li>
<li>什么是支撑位？</li>
<li>分红强者：3 只为长期投资而生的蓝筹股</li>
<li>最佳能源股票 - 现在值得购买的能源股票</li>
<li>2026 年应避免的 3 只最近被下调评级的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
<p>在考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

直觉外科

<p>富国银行将直觉外科（NASDAQ:ISRG）的目标价格从 600 美元上调至 654 美元，维持 “增持” 评级，表明潜在上涨幅度为 19.48%。其他券商也调整了他们的目标价格，普遍评级为 “适度买入”，目标价格为 608.79 美元。直觉外科报告了强劲的季度收益，超出预期，内部人士最近出售了股份。对冲基金也调整了在该公司的持仓</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective upped by Wells Fargo &amp; Company from $600.00 to $654.00 in a report issued on Friday,MarketScreener reports. The brokerage currently has an &#34;overweight&#34; rating on the medical equipment provider's stock. Wells Fargo &amp; Company's target price indicates a potential upside of 19.48% from the company's previous close.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）在周五发布的报告中，Wells Fargo &amp; Company 将其目标价格从 600.00 美元上调至 654.00 美元，MarketScreener 报道。该券商目前对这家医疗设备提供商的股票给予 “增持” 评级。Wells Fargo &amp; Company 的目标价格表明，相较于公司之前的收盘价，存在 19.48% 的潜在上涨空间。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 警报：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 亿美元的内部交易：这对 KMI、ISRG 和 QS 可能意味着什么</li>
</ul>
</div><p>A number of other brokerages also recently issued reports on ISRG. Leerink Partners upped their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 22nd. Sanford C. Bernstein restated an &#34;outperform&#34; rating and set a $685.00 price target on shares of Intuitive Surgical in a research report on Tuesday, October 21st. BTIG Research raised their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, October 22nd. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Hsbc Global Res upgraded shares of Intuitive Surgical to a &#34;strong-buy&#34; rating in a research note on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $608.79.</p>
<div class="lb-trans"><p>其他一些券商最近也发布了关于 ISRG 的报告。Leerink Partners 将直觉外科的目标价格从 593.00 美元上调至 600.00 美元，并在 10 月 22 日的研究报告中给予该公司 “跑赢大盘” 评级。Sanford C. Bernstein 在 10 月 21 日的研究报告中重申了 “跑赢大盘” 评级，并设定了 685.00 美元的目标价格。BTIG Research 在 10 月 22 日的报告中将直觉外科的目标价格从 529.00 美元上调至 589.00 美元，并给予该股票 “买入” 评级。Weiss Ratings 在 10 月 31 日的研究报告中重申了对直觉外科股票的 “持有（c）” 评级。最后，HSBC Global Research 在 10 月 23 日的研究报告中将直觉外科的股票评级上调至 “强力买入”。两位股票研究分析师给予该股票 “强力买入” 评级，十六位给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，共识目标价格为 608.79 美元。</p>
</div><p><strong>View Our Latest Research Report on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们关于直觉外科的最新研究报告</strong></p>
</div><h2>Intuitive Surgical Stock Performance</h2>
<div class="lb-trans"><h2>直觉外科股票表现</h2>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普关税政策下表现突出的三只股票</li>
</ul>
</div><p>NASDAQ:ISRG opened at $547.36 on Friday. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50-day moving average price of $527.82 and a two-hundred day moving average price of $505.98. The firm has a market cap of $196.22 billion, a price-to-earnings ratio of 72.40, a price-to-earnings-growth ratio of 5.11 and a beta of 1.68.</p>
<div class="lb-trans"><p>NASDAQ:ISRG 周五开盘价为 547.36 美元。直觉外科的 52 周低点为 425.00 美元，52 周高点为 616.00 美元。该公司的 50 日移动平均价格为 527.82 美元，200 日移动平均价格为 505.98 美元。该公司的市值为 1962.2 亿美元，市盈率为 72.40，市盈增长比率为 5.11，贝塔值为 1.68。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical's quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical will post 6.43 earnings per share for the current year.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近于 10 月 21 日发布了其财报。这家医疗设备提供商报告本季度每股收益（EPS）为 2.40 美元，超出市场共识预期的 1.99 美元，超出幅度为 0.41 美元。该公司本季度的收入为 25.1 亿美元，而分析师预期为 24.1 亿美元。直觉外科的股本回报率为 15.08%，净利润率为 28.58%。直觉外科的季度收入同比增长 22.9%。在去年同期，该公司每股收益为 1.84 美元。整体来看，卖方分析师预测直觉外科在当前年度的每股收益将达到 6.43 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么直觉外科对长期投资者来说是个明智的选择</li>
</ul>
</div><p>In related news, insider Gary S. Guthart sold 28,800 shares of the firm's stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the transaction, the insider directly owned 27,027 shares of the company's stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the business's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 109,043 shares of company stock valued at $60,816,225. 0.70% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，内部人士 Gary S. Guthart 于 10 月 24 日星期五出售了 28,800 股公司的股票。该股票以平均价格 547.56 美元出售，总价值为 15,769,728.00 美元。交易完成后，该内部人士直接持有 27,027 股公司股票，价值约为 14,798,904.12 美元。这笔交易代表其持股比例减少了 51.59%。该交易已在证券交易委员会的备案中披露，相关信息可通过此链接访问。此外，首席执行官 David J. Rosa 于 10 月 24 日星期五出售了 24,500 股公司的股票。该股票以平均价格 547.55 美元出售，总交易额为 13,414,975.00 美元。出售后，首席执行官直接持有 234,256 股公司股票，价值为 128,266,872.80 美元。这笔交易使其持股比例减少了 9.47%。该出售的 SEC 备案提供了更多信息。在过去三个月中，内部人士已出售 109,043 股公司股票，价值为 60,816,225 美元。当前 0.70% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>对直觉外科的对冲基金看法</h2>
</div><p>Several hedge funds have recently made changes to their positions in ISRG. Alecta Tjanstepension Omsesidigt boosted its stake in Intuitive Surgical by 25.4% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 212,800 shares of the medical equipment provider's stock worth $95,160,000 after purchasing an additional 43,100 shares during the period. Saranac Partners Ltd purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $4,325,000. Swiss Life Asset Management Ltd boosted its position in shares of Intuitive Surgical by 7.7% in the third quarter. Swiss Life Asset Management Ltd now owns 67,483 shares of the medical equipment provider's stock valued at $30,180,000 after acquiring an additional 4,824 shares during the period. Cambria Investment Management L.P. bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $318,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in Intuitive Surgical during the third quarter valued at approximately $33,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>几家对冲基金最近对 ISRG 的持仓进行了调整。Alecta Tjanstepension Omsesidigt 在第三季度将其在直觉外科的股份增加了 25.4%。Alecta Tjanstepension Omsesidigt 目前持有 212,800 股该医疗设备提供商的股票，价值为 95,160,000 美元，此前在该期间内又购买了 43,100 股。Saranac Partners Ltd 在第三季度购买了直觉外科的新股份，价值约为 4,325,000 美元。瑞士人寿资产管理有限公司在第三季度将其在直觉外科的股份增加了 7.7%。瑞士人寿资产管理有限公司目前持有 67,483 股该医疗设备提供商的股票，价值为 30,180,000 美元，此前在该期间内又收购了 4,824 股。Cambria Investment Management L.P.在第三季度购买了直觉外科的新股份，价值约为 318,000 美元。最后，KERR FINANCIAL PLANNING Corp 在第三季度购买了直觉外科的新股份，价值约为 33,000 美元。当前 83.64% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>关于直觉外科</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直觉外科公司开发、制造和销售产品，使医生和医疗服务提供者能够提高美国及国际上微创护理的质量和可及性。该公司提供达芬奇手术系统，能够以微创方式进行复杂手术；以及 Ion 内腔系统，扩展其商业产品范围，涵盖微创肺活检的诊断程序。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Why Are Stock Sectors Important to Successful Investing?</li>
<li>4 Canadian Oil Stocks That Are Filling the Heavy Crude Gap</li>
<li>What is a support level?</li>
<li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li>
<li>Best Energy Stocks - Energy Stocks to Buy Now</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比直觉外科更好的股票</li>
<li>股票行业对成功投资的重要性是什么？</li>
<li>4 只填补重油缺口的加拿大石油股票</li>
<li>什么是支撑位？</li>
<li>分红强者：3 只为长期投资而生的蓝筹股</li>
<li>最佳能源股票 - 现在值得购买的能源股票</li>
<li>2026 年应避免的 3 只最近被下调评级的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

富国银行公司对直觉外科（NASDAQ 代码：ISRG）的股票价格发布了乐观的预测